⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory or relapsed aml

Every month we try and update this database with for refractory or relapsed aml cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCYNCT00809276
Lymphoma
Multiple Myelom...
Leukemia
Myelodysplastic...
Busulfan, Fluda...
- 65 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)NCT01147939
Acute Myeloid L...
Elacytarabine
Investigator's ...
18 Years - Clavis Pharma
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)NCT01147939
Acute Myeloid L...
Elacytarabine
Investigator's ...
18 Years - Clavis Pharma
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)NCT01147939
Acute Myeloid L...
Elacytarabine
Investigator's ...
18 Years - Clavis Pharma
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: